Hims is making its Super Bowl debut with an ad that goes straight for pharma
Hims & Hers releases Super Bowl ad criticizing pharmaceutical industry and weight loss market, promoting their compounded GLP-1 drugs while…
33,960$
6,59%
Echtzeit-Aktienkurs Hims & Hers Health Inc.
Bid:
Ask:
Nachrichten zur Hims & Hers Health Inc. Aktie
Hims & Hers Stock Surges 69.2% in Three Months: Whats Next?
HIMS is enhancing its offerings and expanding the breadth of health and wellness products and services. However, macro challenges are…
Hims & Hers Stock Surges 69.2% in Three Months: Whats Next?
HIMS is enhancing its offerings and expanding the breadth of health and wellness products and services. However, macro challenges are…
Hims & Hers Health, Inc. (HIMS) Increases Despite Market Slip: Heres What You Need to Know
Hims & Hers Health, Inc. (HIMS) concluded the recent trading session at $31.86, signifying a +1.01% move from its prior…
Pharmalittle: Were reading about a Super Bowl ad for compounded obesity drugs, a PEPFAR waiver, and more
A Super Bowl ad for weight loss medications from telehealth company Hims & Hers is optimized to engage and infuriate…
Genesee Capital Advisors LLC Makes New Investment in Hims & Hers Health, Inc. (NYSE:HIMS)
Genesee Capital Advisors LLC bought a new stake in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) during…
Hims & Hers tackles pharma industry drug pricing in Super Bowl ad for compounded GLP-1s
Telehealth company Hims & Hers is playing offense in a new commercial slated to air during the Super Bowl next…
Hims & Hers: Potential Risks Ahead, But Shorting May Be Premature (HIMS)
Hims & Hers may leverage FDA compounding exemptions to further extend its compounded GLP-1 offerings. Learn why HIMS stock is…
Marketing Daily: Thinner Amid Gluttony? Hims & Hers Debut First SB Ads For Weight-Loss Drugs
Telehealth companys spot decries medications from others as "priced for profits, not patients," while its own weight-loss drugs are "affordable."…
Hims & Hers Health (NYSE:HIMS) Trading 5.7% Higher
Hims & Hers Health (NYSE:HIMS) Trading 5.7% Higher - Still a Buy?…
Hims & Hers set for Super Bowl ad debut highlighting GLP-1 weight loss drugs
Hims & Hers’ decision to advertise at the Super Bowl represents an ambitious play for the brand as it positions…
Hims & Hers wirbt beim Super Bowl für erschwingliche Alternativen zur teuren Gewichtsabnahme
Super Bowl als Bühne: Der Spot hebt Hims & Hers als Anbieter preiswerter und patientenorientierter Lösungen hervor – eine…
Hims & Hers is making a massive bet on a Super Bowl ad this year
The telehealth company is turning to the Super Bowl to market its off-brand Ozempic…
Hims & Hers is making a big bet on a Super Bowl ad
The millennial-targeted telehealth company Hims & Hers (HIMS) is spending big bucks on its first ever Super Bowl commercial to…
Hims & Hers has a new definition for ‘This is America’
The DTC healthcare company is using its first Super Bowl appearance to highlight America’s obesity epidemic.…
Hims & Hers has a new definition for ‘This is America’
The DTC healthcare company is using its first Super Bowl appearance to highlight America’s obesity epidemic.…
Hims & Hers to debut at Super Bowl
Health and wellness platform Hims & Hers is running its first-ever Super Bowl ad aiming to raise awareness around America’s…
Hims & Hers Hopes Super Bowl Commercial About Obesity Stands Apart From Pack of Snacks
Most Super Bowl commercials aim to entertain. A minute-long Big Game ad from telehealth company Hims & Hers Health might…
Hims & Hers Hopes Super Bowl Commercial About Obesity Stands Apart From Pack of Snacks
Hims & Hers, a tele-health start-up, aims to stand apart from dozens of Super Bowl commercials hawking snacks with a…
Hims & Hers to air its first Super Bowl spot, promoting weight loss drugs
Telehealth brand Hims & Hers is taking its weight loss products to the Super Bowl with a 60-second spot.…
Hims & Hers to Advertise Weight-Loss Shots at the Super Bowl
Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced injectables.…
Is Hims & Hers Health Stock a Buy?
Established in 2017, Hims & Hers Health (NYSE: HIMS) is a relatively young company addressing age-old healthcare challenges by offering…
SG Americas Securities LLC Purchases 31,915 Shares of Hims & Hers Health, Inc. (NYSE:HIMS)
SG Americas Securities LLC boosted its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report)…
Why Hims & Hers Health, Inc. (HIMS) Is Skyrocketing Now
We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are…
Why Hims & Hers Health, Inc. (HIMS) Is Skyrocketing Now
We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going…
Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $536,424.00 in Stock
Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Michael Chi sold 17,304 shares of the businesss stock…
Hims & Hers Health, Inc. (NYSE:HIMS) CEO Sells $815,107.84 in Stock
Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) CEO Andrew Dudum sold 27,098 shares of the companys stock…
Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $1,619,174.70 in Stock
Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Soleil Boughton sold 54,153 shares of the businesss stock…
Melissa Baird Sells 67,687 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) Stock
Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) COO Melissa Baird sold 67,687 shares of the businesss stock…
Hims & Hers health chief commercial officer sells $536,424 in stock
Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc. (NYSE:HIMS), reported a significant transaction involving the companys stock.…
Hims & Hers CEO Andrew Dudum sells $815k in stock By Investing.com
Hims & Hers CEO Andrew Dudum sells $815k in stock…
Hims & Hers health chief commercial officer sells $536,424 in stock By Investing.com
Hims & Hers health chief commercial officer sells $536,424 in stock…
hims & hers CEO Andrew Dudum sells shares worth $438,184
Andrew Dudum, the Chief Executive Officer of Hims & Hers Health, Inc. (NYSE:HIMS), recently executed a series of stock transactions,…
Hims & Hers health chief legal officer sells shares worth over $1.6 million
San Francisco—Boughton Soleil, the Chief Legal Officer of Hims & Hers Health, Inc. (NYSE:HIMS), recently executed a series of stock…
Hims & Hers health COO Melissa Baird sells shares worth $1.99 million
Melissa Baird, the Chief Operating Officer of Hims & Hers Health, Inc. (NYSE:HIMS), recently executed a series of stock transactions…
hims & hers CEO Andrew Dudum sells shares worth $438,184 By Investing.com
hims & hers CEO Andrew Dudum sells shares worth $438,184…
hims & hers CEO Andrew Dudum sells shares worth $438,184 By Investing.com
hims & hers CEO Andrew Dudum sells shares worth $438,184…
hims & hers CEO Andrew Dudum sells shares worth $438,184 By Investing.com
hims & hers CEO Andrew Dudum sells shares worth $438,184…
Hims & Hers health chief legal officer sells shares worth over $1.6 million By Investing.com
Hims & Hers health chief legal officer sells shares worth over $1.6 million…
Hims & Hers health COO Melissa Baird sells shares worth $1.99 million By Investing.com
Hims & Hers health COO Melissa Baird sells shares worth $1.99 million…
Hims & Hers Health, Inc. (HIMS) Stock Declines While Market Improves: Some Information for Investors
Hims & Hers Health, Inc. (HIMS) closed at $29.72 in the latest trading session, marking a -0.3% move from the…
Hims & Hers Health, Inc. (HIMS) Stock Declines While Market Improves: Some Information for Investors
Hims & Hers Health, Inc. (HIMS) concluded the recent trading session at $29.72, signifying a -0.3% move from its prior…
Andrew Dudum Sells 36,460 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) Stock
Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) CEO Andrew Dudum sold 36,460 shares of the companys stock…
S.F. doughnut shop owned by startup CEO faces backlash over his company’s $1 million Trump donation
The doughnut shop owner’s startup, Hims & Hers, made a seven-figure donation to...…
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by Antonio Linares. In this…
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by Antonio Linares. In this article, we…
Owner of Hims & Hers Healthcare Company, and New West Portal Doughnut Shop, Donates to Trump Inauguration
Andrew Dudum, and his company Hims & Hers Health, just kicked $1 million to Donald Trumps inauguration fund, perhaps because…
Hims & Hers CEO Andrew Dudum sells $2.27 million in stock By Investing.com
Hims & Hers CEO Andrew Dudum sells $2.27 million in stock…
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine…
Hims & Hers Health Inc (HIMS) Shares Up 6.03% on Jan 21
Shares of Hims & Hers Health Inc (HIMS) surged 6.03% in mid-day trading on Jan 21. The stock reached an…